Treatment of autoimmune diseases by oral tolerance to autoantigens.
Weiner
H L
HL
Center for Neurologic Diseases, Brigham and Women's Hospital, USA.
Miller
A
A
Khoury
S J
SJ
Zhang
Z J
ZJ
al-Sabbagh
A
A
Brod
S A
SA
Lider
O
O
Higgins
P
P
Sobel
R
R
Matsui
M
M
D000284:Administration, Oral; D000818:Animals; D001169:Arthritis, Experimental / Q000276:immunology / Q000628:therapy; D001324:Autoantigens / Q000008:administration & dosage*; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D003888:Desensitization, Immunologic; D003922:Diabetes Mellitus, Type 1 / Q000276:immunology / Q000628:therapy; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance; D018928:Immunity, Mucosal; D007165:Immunosuppression Therapy; D051379:Mice; D004676:Myelin Basic Protein / Q000008:administration & dosage / Q000276:immunology; D010581:Peyer's Patches / Q000276:immunology; D051381:Rats
D001324:Autoantigens; D004676:Myelin Basic Protein